预测性和个性化医疗的词汇领域。

Thierry Mathieu, Laurent Bermont, Jean-Christophe Boyer, Céline Versuyft, Alexandre Evrard, Isabelle Cuvelier, Remy Couderc, Katell Peoc'h
{"title":"预测性和个性化医疗的词汇领域。","authors":"Thierry Mathieu,&nbsp;Laurent Bermont,&nbsp;Jean-Christophe Boyer,&nbsp;Céline Versuyft,&nbsp;Alexandre Evrard,&nbsp;Isabelle Cuvelier,&nbsp;Remy Couderc,&nbsp;Katell Peoc'h","doi":"10.1515/dmdi-2013-0024","DOIUrl":null,"url":null,"abstract":"<p><p>With human genome mapping, the omics revolution and the empowering sequencing technologies developed at the turn of the century, the new goals in medicine are to switch from population medicine to individualized therapies, not only to cure diseases but also to prevent them. The purpose of this review by the pharmacogenetics and predictive medicine working group of the French clinical biology society (SFBC) is to situate in their correct context the notions of personalized medicine, pharmacogenetics, genetics and genomics, emphasizing their interactions and discussing their significance for researchers and clinicians.</p>","PeriodicalId":11319,"journal":{"name":"Drug Metabolism and Drug Interactions","volume":"28 2","pages":"125-32"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/dmdi-2013-0024","citationCount":"0","resultStr":"{\"title\":\"Lexical fields of predictive and personalized medicine.\",\"authors\":\"Thierry Mathieu,&nbsp;Laurent Bermont,&nbsp;Jean-Christophe Boyer,&nbsp;Céline Versuyft,&nbsp;Alexandre Evrard,&nbsp;Isabelle Cuvelier,&nbsp;Remy Couderc,&nbsp;Katell Peoc'h\",\"doi\":\"10.1515/dmdi-2013-0024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>With human genome mapping, the omics revolution and the empowering sequencing technologies developed at the turn of the century, the new goals in medicine are to switch from population medicine to individualized therapies, not only to cure diseases but also to prevent them. The purpose of this review by the pharmacogenetics and predictive medicine working group of the French clinical biology society (SFBC) is to situate in their correct context the notions of personalized medicine, pharmacogenetics, genetics and genomics, emphasizing their interactions and discussing their significance for researchers and clinicians.</p>\",\"PeriodicalId\":11319,\"journal\":{\"name\":\"Drug Metabolism and Drug Interactions\",\"volume\":\"28 2\",\"pages\":\"125-32\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1515/dmdi-2013-0024\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Metabolism and Drug Interactions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/dmdi-2013-0024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism and Drug Interactions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/dmdi-2013-0024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

随着人类基因组图谱、组学革命和本世纪初开发的赋能测序技术的发展,医学的新目标是从人口医学转向个性化治疗,不仅要治愈疾病,还要预防疾病。法国临床生物学学会(SFBC)药物遗传学和预测医学工作组的这篇综述的目的是在正确的背景下定位个性化医学、药物遗传学、遗传学和基因组学的概念,强调它们的相互作用,并讨论它们对研究人员和临床医生的意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Lexical fields of predictive and personalized medicine.

With human genome mapping, the omics revolution and the empowering sequencing technologies developed at the turn of the century, the new goals in medicine are to switch from population medicine to individualized therapies, not only to cure diseases but also to prevent them. The purpose of this review by the pharmacogenetics and predictive medicine working group of the French clinical biology society (SFBC) is to situate in their correct context the notions of personalized medicine, pharmacogenetics, genetics and genomics, emphasizing their interactions and discussing their significance for researchers and clinicians.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
An Integrated Approach to Assessing Drug-Drug Interactions: A Regulatory Perspective The Role of P-Glycoprotein in Drug Disposition: Significance to Drug Development In Vitro Approaches for Studying the Inhibition of Drug-Metabolizing Enzymes and Identifying the Drug-Metabolizing Enzymes Responsible for the Metabolism of Drugs (Reaction Phenotyping) with Emphasis on Cytochrome P450 Drug-Drug Interactions: Marketing Perspectives Cytochrome P450 Protein Modeling and Ligand Docking
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1